Patents/Inventors

Christos Kyratsous

Irvington, NYUS20 patents

19 Patents

US125891682026
Compositions and Methods for Treating Sensorineural Hearing Loss Using Otoferlin Dual Vector Systems
Regeneron Pharmaceuticals, Inc.
0 cites
US125528562026
Anti-pcrv Antibodies That Bind PCRV, Compositions Comprising Anti-pcrv Antibodies, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US124964702025
Anti-sars-cov-2-spike Glycoprotein Antibodies and Antigen-binding Fragments
Regeneron Pharmaceuticals, Inc.
0 cites
US124974602025
Anti-msr1 Antibodies and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US124599912025
Compositions and Methods for Using Bispecific Antibodies to Bind Complement and a Target Antigen
REGENERON PHARMACEUTICALS, Inc.
0 cites
US124104422025
Compositions and Methods for Treating Sensorineural Hearing Loss Using Otoferlin Dual Vector Systems
Decibel Therapeutics, Inc.
0 cites
US124045052025
Delivery of a Gene-editing System with a Single Retroviral Particle and Methods of Generation and Use
Regeneron Pharmaceuticals, Inc.
0 cites
US122567202025
Humanized Dipeptidyl-peptidase IV (DPP4) Animals
Regeneron Pharmaceuticals, Inc.
0 cites
US122514402025
Anti-sars-cov-2-spike Glycoprotein Antibodies and Antigen-binding Fragments
Regeneron Pharmaceuticals, Inc.
0 cites
US122525202025
Myosin 15 Promoters and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US122140232025
Compositions and Methods for Expressing Factor IX
Regeneron Pharmaceuticals, Inc.
0 cites
US122151382025
Compositions and Methods for Internalizing Enzymes
Regeneron Pharmaceuticals, Inc.
0 cites
US121520672024
Human Antibodies to Ebola Virus Glycoprotein
Regeneron Pharmaceuticals, Inc.
0 cites
US120245562024
Anti- Staphylococcus Antibodies and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US119997992024
Anti-tmprss2 Antibodies and Antigen-binding Fragments
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117731562023
Anti-hemagglutinin Antibodies and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117320302023
Anti-sars-cov-2-spike Glycoprotein Antibodies and Antigen-binding Fragments
Regeneron Pharmaceuticals, Inc.
0 cites
US116965722023
Non-human Animals Comprising a Humanized ASGR1 Locus
Regeneron Pharmaceuticals, Inc.
0 cites
US116552862023
Anti-pcrv Antibodies That Bind Pcrv, Compositions Comprising Anti-pcrv Antibodies, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites